Cagrilintide 10 mg research vial with Sentient Biogenix label

Cagrilintide 10mg

$99.00 CAD

Cagrilintide is a long-acting amylin analogue studied alongside incretin research for its effects on satiety signalling and energy balance, and investigated both alone and in combination with GLP-1 receptor agonists.

Pep-Pedia link

In stock

Volume pricing — mix and match any vials

Discount is applied automatically in your cart. Any combination of vials counts toward the tier — they do not have to be the same compound. Syringes and swabs are excluded.

This ships as dry powder. It takes 2 mL of bacteriostatic water to reconstitute, and you will need syringes and swabs to draw and dose it. The Research Starter Kit has all of it in one line.

Category:

Description

Cagrilintide is a synthetic, long-acting analogue of amylin, the pancreatic hormone co-secreted with insulin. Research interest centres on amylin receptor signalling in satiety and gastric emptying, and on how that pathway behaves alongside GLP-1 receptor agonism rather than in place of it. Supplied as a 10 mg lyophilised vial.

*Sentient Biogenix products are intended solely for non-clinical laboratory research. It is not approved by Health Canada, the FDA, or any other regulatory authority, and is not for human or animal consumption, nor for diagnostic, therapeutic, or clinical use.

Share your thoughts!

Let us know what you think...

Leave a Review Ask a Question Post a Video Post a Photo

What others are saying

There are no contributions yet.

×

Login

Register


Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.

Continue as a Guest

Don't have an account? Sign Up

Continue as a Guest